To clarify the impact of DHX9 on the malignant phenotype of BC cells, DHX9 was transiently overexpressed or downregulated in MCF7 and MDA-MB-231 cells, with transfection efficacy validated via Western blotting (Figure S2A). This evidence concerns the gene DHX9 and breast cancer.